SCHEMBL23832913

SCHEMBL23832913

CC(C)CC(NC(=O)OC(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 7/20 0.55
KMT2A Q03164 3/20 0.52
RAB9A P51151 1/20 0.50
CMA1 P23946 1/20 0.49
MAPK1 P28482 1/20 0.48
REN P00797 4/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.48
F2 P00734 1/20 0.48
LTA4H P09960 1/20 0.48
MAPT P10636 1/20 0.48
PEPD P12955 1/20 0.48
ALOX15 P16050 1/20 0.48
PTGS1 P23219 1/20 0.48
HTR2A P28223 1/20 0.48
PTGS2 P35354 1/20 0.48
HRH1 P35367 1/20 0.48
THPO P40225 1/20 0.48
PMP22 Q01453 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2262043 1.00 ACE (0.55) ACEKMT2ARAB9ACMA1MAPK1
SCHEMBL10935144 1.00 ACE (0.55) ACEKMT2ARAB9ACMA1MAPK1
SCHEMBL9510956 0.90 KMT2A (0.52) ACEKMT2ACMA1MAPK1LMNA
SCHEMBL22070275 0.88 ACE (0.57) ACECMA1RENLMNAKDM4E
SCHEMBL6242285 0.88 ACE (0.57) ACECMA1RENLMNAKDM4E
SCHEMBL22070276 0.88 ACE (0.57) ACECMA1RENLMNAKDM4E
SCHEMBL7563228 0.87 ACE (0.56) ACECMA1RENLMNAKDM4E
SCHEMBL20174030 0.87 ACE (0.67) ACECMA1MAPK1RENF2
SCHEMBL13667609 0.86 ACE (0.55) ACECMA1RENLMNAKDM4E
SCHEMBL23795536 0.86 ACE (0.55) ACECMA1RENLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121055-A1 STAT DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-01-25 EP disclosed
WO-2021188696-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed